In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin
about
Effect of microneedle treatment on the skin permeation of a nanoencapsulated dyeMicro Electromechanical Systems (MEMS) Based Microfluidic Devices for Biomedical Applications.Novel 3-O-pegylated carboxylate and 3-O-pegylated carbamate prodrugs of naltrexone for microneedle-enhanced transdermal delivery.Microneedle/nanoencapsulation-mediated transdermal delivery: mechanistic insightsMicroneedles for drug and vaccine deliveryProdrugs of theophylline incorporating ethyleneoxy groups in the promoiety: synthesis, characterization, and transdermal deliveryMicroneedle-assisted percutaneous delivery of naltrexone hydrochloride in yucatan minipig: in vitro-in vivo correlation.Microneedles: an emerging transdermal drug delivery system.Microarrays and microneedle arrays for delivery of peptides, proteins, vaccines and other applications.Biomedical applications of microneedles in therapeutics: recent advancements and implications in drug delivery.Prodrugs for transdermal drug delivery - trends and challenges.Stability, cutaneous delivery, and antioxidant potential of a lipoic acid and α-tocopherol codrug incorporated in microemulsionsSynthesis and in vitro stability of amino acid prodrugs of 6-β-naltrexol for microneedle-enhanced transdermal deliveryOptimization of naltrexone diclofenac codrugs for sustained drug delivery across microneedle-treated skin.Effect of oleic acid modified polymeric bilayered nanoparticles on percutaneous delivery of spantide II and ketoprofen.Effect of formulation pH on transport of naltrexone species and pore closure in microneedle-enhanced transdermal drug delivery.Dissolving microneedles for enhanced local delivery of capsaicin to rat skin tissue.Enhanced skin delivery of vismodegib by microneedle treatment.
P2860
Q28391616-5E973662-7911-4E18-83DC-A040897B6F33Q30474857-00099766-633E-4F2A-B31B-6CC68E1E9060Q33572370-CCAAFE01-2C8B-407A-80D0-77C49DE59D4FQ34609195-6EF6DEB4-25C5-43D2-AC24-F5E01FB6616BQ36164749-6498B14E-958D-45F5-9E45-098934EB97BDQ36195140-20B2A28E-5494-4515-91FD-3858B690D2CFQ37359303-71C94A62-C3DF-4308-91A5-4BEE32C1B055Q37965845-F4953BD0-FD78-4AAF-833C-B9591848B230Q38105616-93DC0309-C393-414C-A62D-25733271F6D2Q38630763-04673984-11E9-457D-A097-F89AB9726DCFQ38733942-4B3F0C9E-D78B-476D-A55D-D0E38DCC135EQ41146412-9C049644-3DC4-4A17-AD2E-9238B2A469B0Q41781622-318B9038-8CA8-4185-B960-59CFFF75C739Q41964832-FBAE5C56-09FE-4E2B-B7BF-FA354FB62724Q42183286-34357ECC-77DE-45B6-9FCE-883D4AC4A1ABQ43082308-E1D60A58-2528-4A2E-BB64-F8D400C3A267Q51027898-C3F914D7-BCDC-4D23-8E9C-07A3B4CCF72CQ53469451-F1DE74B4-B0DF-4F11-B0BC-04E0101EB749
P2860
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin
@en
type
label
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin
@en
prefLabel
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin
@en
P2093
P2860
P1476
In vitro permeation of a pegylated naltrexone prodrug across microneedle-treated skin
@en
P2093
Audra L Stinchcomb
Mikolaj Milewski
Peter A Crooks
Priyanka Ghosh
Thirupathi Reddy Yerramreddy
P2860
P356
10.1016/J.JCONREL.2010.05.034
P407
P577
2010-06-04T00:00:00Z